No Data
No Data
No Data
No Data
No Data
Express News | Immunic Announces Publication of Extended Data From Phase 2 Emphasis Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis in the Peer Reviewed Journal, Neurology® Neuroimmunology & Neuroinflammation
Reuters06:30 ET
Immunic CEO Dr Daniel Vitt Marks International Day of Immunology With Discussion on Its Crucial Role
Yahoo FinanceApr 29 11:11 ET
Analysts Offer Insights on Healthcare Companies: Adaptimmune Therapeutics (ADAP) and Immunic (IMUX)
TipRanksApr 16 02:50 ET
Top 10 Stocks With Upwards and Downwards Daily Percentage Change - Piper Sandler
Seeking AlphaApr 12 11:34 ET
Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), DocGo (DCGO) and Alkermes (ALKS)
TipRanksApr 10 07:20 ET
Brookline Capital Starts Immunic at Buy, Cites MS Drug Candidate
Seeking AlphaApr 5 13:00 ET
No Data
No Data